The ERK signaling pathway, which is activated by SEMA3C in cervical cancer, is a well-known signaling cascade that transmits signals from cell surface receptors to promote proliferation and survival programs in a high percentage of tumors (28–31), including cervical cancer (32). Here, CD177 is linked to cervical carcinoma.